THE DEAL, AT A GLANCE
From the announcementREMEDY
01What it doesREMEDY is building a clinical skincare brand around dermatologist-developed products for the mass dermocosmetic market.From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02Who is involvedBacked by L CattertonFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗03What happenedREMEDY raised Series A, announced 2026-06-11From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗04Why it mattersREMEDY's Series A is a sector-positioning and investor-sponsorship signal rather than a disclosed-size capital signal, with the round recorded at $0M against a…From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
REMEDY · Financing Record
Explore source-linked visual explanations for REMEDY. Unsupported claims are withheld while source review continues.
Record 5924 · Recorded date: 2026-06-11
Explore company records →